Ritonavir

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 65862-687
  • Package NDC 65862-687-01
  • Package NDC 65862-687-05
  • Package NDC 65862-687-30
  • Package NDC 65862-687-99
  • Application number ANDA206614
  • SPL ID 35e7d4f2-b970-4126-8919-0c57d01e1e7b
  • SPL set ID 11f757f1-cf48-47a8-925e-918359cbd2d4
  • UNII O3J8G9O825
  • RxCUI 900575

What the source publishes

Labeler
Aurobindo Pharma Limited
Active ingredients
Ritonavir
Form
TABLET, FILM COATED
Routes
ORAL
Administrative status
present-in-source-snapshot
Marketing status
ANDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:65862-687_35e7d4f2-b970-4126-8919-0c57d01e1e7b
{
  "name": "Ritonavir",
  "splId": "35e7d4f2-b970-4126-8919-0c57d01e1e7b",
  "labels": [
    {
      "setId": "11f757f1-cf48-47a8-925e-918359cbd2d4",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=11f757f1-cf48-47a8-925e-918359cbd2d4",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=11f757f1-cf48-47a8-925e-918359cbd2d4"
    }
  ],
  "routes": [
    "ORAL"
  ],
  "labeler": "Aurobindo Pharma Limited",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "100 TABLET, FILM COATED in 1 BOTTLE (65862-687-01)",
      "package_ndc": "65862-687-01",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20180917"
    },
    {
      "sample": false,
      "description": "500 TABLET, FILM COATED in 1 BOTTLE (65862-687-05)",
      "package_ndc": "65862-687-05",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20180917"
    },
    {
      "sample": false,
      "description": "30 TABLET, FILM COATED in 1 BOTTLE (65862-687-30)",
      "package_ndc": "65862-687-30",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20180917"
    },
    {
      "sample": false,
      "description": "1000 TABLET, FILM COATED in 1 BOTTLE (65862-687-99)",
      "package_ndc": "65862-687-99",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20180917"
    }
  ],
  "productId": "65862-687_35e7d4f2-b970-4126-8919-0c57d01e1e7b",
  "useDomain": "unknown",
  "dosageForm": "TABLET, FILM COATED",
  "productNdc": "65862-687",
  "deaSchedule": null,
  "genericName": "Ritonavir",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "RITONAVIR",
      "strength": "100 mg/1"
    }
  ],
  "applicationNumber": "ANDA206614",
  "marketingCategory": "ANDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20180917",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "nui": [
      "N0000000246",
      "N0000191001",
      "N0000175889",
      "N0000190114",
      "N0000182137",
      "N0000185607",
      "N0000190118",
      "N0000185503",
      "N0000190113",
      "N0000182141",
      "N0000191266",
      "N0000185507",
      "N0000187064",
      "N0000190117"
    ],
    "upc": [
      "0365862687302"
    ],
    "unii": [
      "O3J8G9O825"
    ],
    "rxcui": [
      "900575"
    ],
    "spl_set_id": [
      "11f757f1-cf48-47a8-925e-918359cbd2d4"
    ],
    "pharm_class_epc": [
      "Cytochrome P450 3A Inhibitor [EPC]",
      "Protease Inhibitor [EPC]"
    ],
    "pharm_class_moa": [
      "HIV Protease Inhibitors [MoA]",
      "Cytochrome P450 3A Inhibitors [MoA]",
      "Cytochrome P450 2D6 Inhibitors [MoA]",
      "Cytochrome P450 2C19 Inducers [MoA]",
      "Cytochrome P450 3A Inducers [MoA]",
      "P-Glycoprotein Inhibitors [MoA]",
      "Breast Cancer Resistance Protein Inhibitors [MoA]",
      "Cytochrome P450 3A4 Inhibitors [MoA]",
      "Cytochrome P450 1A2 Inducers [MoA]",
      "Cytochrome P450 2C9 Inducers [MoA]",
      "Cytochrome P450 2B6 Inducers [MoA]",
      "UDP Glucuronosyltransferases Inducers [MoA]"
    ],
    "manufacturer_name": [
      "Aurobindo Pharma Limited"
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:65862-687_35e7d4f2-b970-4126-8919-0c57d01e1e7b"